|
1.Barres NJAaBA. Glia-more than just brain glue. Neuroscience nature. 2009;457. 2.Barisic N, Claeys KG, Sirotkovic-Skerlev M, Lofgren A, Nelis E, De Jonghe P, et al. Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Annals of human genetics. 2008;72(Pt 3):416-41. 3.Jerath NU, Shy ME. Hereditary motor and sensory neuropathies: Understanding molecular pathogenesis could lead to future treatment strategies. Biochim Biophys Acta. 2015;1852(4):667-78. 4.Sultzer DL, Leskin LP, Melrose RJ, Harwood DG, Narvaez TA, Ando TK, et al. Neurobiology of delusions, memory, and insight in Alzheimer disease. Am J Geriatr Psychiatry. 2014;22(11):1346-55. 5.Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, et al. The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment. J Alzheimers Dis. 2010;19(3):909-14. 6.Ambasudhan R, Talantova M, Coleman R, Yuan X, Zhu S, Lipton SA, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell stem cell. 2011;9(2):113-8. 7.Hurwitz B. Urban observation and sentiment in James Parkinson's Essay on the Shaking Palsy (1817). Lit Med. 2014;32(1):74-104. 8.Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. The Lancet Neurology. 2012;11(6):521-34. 9.Fallerini C, Carignani G, Capoccitti G, Federico A, Rufa A, Pinto AM, et al. Sporadic hereditary motor and sensory neuropathies: Advances in the diagnosis using next generation sequencing technology. J Neurol Sci. 2015;359(1-2):409-17. 10.Higa GM, Sypult C. Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy. Clin Med Insights Oncol. 2016;10:27-34. 11.Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. Journal of neurology, neurosurgery, and psychiatry. 2009;80(12):1304-14. 12.Hachem LD, Mothe AJ, Tator CH. Evaluation of the effects of riluzole on adult spinal cord-derived neural stem/progenitor cells in vitro and in vivo. Int J Dev Neurosci. 2015;47(Pt B):140-6. 13.Marino MJ, Williams DL, Jr., O'Brien JA, Valenti O, McDonald TP, Clements MK, et al. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(23):13668-73. 14.Cilia R, Siri C, Canesi M, Zecchinelli AL, De Gaspari D, Natuzzi F, et al. Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome. Journal of neurology, neurosurgery, and psychiatry. 2014;85(3):311-8. 15.Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. 16.Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-72. 17.Thomson M, Liu SJ, Zou LN, Smith Z, Meissner A, Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell. 2011;145(6):875-89. 18.Nishi M, Akutsu H, Masui S, Kondo A, Nagashima Y, Kimura H, et al. A distinct role for Pin1 in the induction and maintenance of pluripotency. J Biol Chem. 2011;286(13):11593-603. 19.Koyanagi-Aoi M, Ohnuki M, Takahashi K, Okita K, Noma H, Sawamura Y, et al. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(51):20569-74. 20.Ring KL, Tong LM, Balestra ME, Javier R, Andrews-Zwilling Y, Li G, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell stem cell. 2012;11(1):100-9. 21.Wattanapanitch M, Klincumhom N, Potirat P, Amornpisutt R, Lorthongpanich C, Y Up, et al. Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages. PLoS One. 2014;9(9):e106952. 22.Li Y, Liu M, Yan Y, Yang ST. Neural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrix. World J Stem Cells. 2014;6(1):11-23. 23.Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc. 2012;7(12):2080-9. 24.Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W, et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16:84. 25.Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, Jimenez-Delgado S, Caig C, Mora S, et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med. 2012;4(5):380-95. 26.Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373(9680):2055-66. 27.Cookson MR. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci. 2010;11(12):791-7. 28.Chanda S, Ang CE, Davila J, Pak C, Mall M, Lee QY, et al. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Reports. 2014;3(2):282-96. 29.Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476(7359):220-3. 30.Hsu YC, Chen SL, Wang YJ, Chen YH, Wang DY, Chen L, et al. Signaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neurons. Stem Cells Transl Med. 2014;3(6):713-22. 31.Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature. 2009;460(7259):1154-8. 32.Ishii R, Kami D, Toyoda M, Makino H, Gojo S, Ishii T, et al. Placenta to cartilage: direct conversion of human placenta to chondrocytes with transformation by defined factors. Mol Biol Cell. 2012;23(18):3511-21. 33.Marro S, Pang ZP, Yang N, Tsai MC, Qu K, Chang HY, et al. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell stem cell. 2011;9(4):374-82. 34.Karow M, Sanchez R, Schichor C, Masserdotti G, Ortega F, Heinrich C, et al. Reprogramming of pericyte-derived cells of the adult human brain into induced neurona cells. Cell stem cell. 2012;11(4):471-6. 35.Addis RC, Hsu FC, Wright RL, Dichter MA, Coulter DA, Gearhart JD. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One. 2011;6(12):e28719. 36.Wang L, Wang L, Huang W, Su H, Xue Y, Su Z, et al. Generation of integration-free neural progenitor cells from cells in human urine. Nat Methods. 2013;10(1):84-9. 37.Zhang SZ, Ma LX, Qian WJ, Li HF, Wang ZF, Wang HX, et al. Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons. Stem Cells Int. 2016;2016:2452985. 38.Lang R, Liu G, Shi Y, Bharadwaj S, Leng X, Zhou X, et al. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One. 2013;8(1):e53980. 39.Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011;21(3):518-29. 40.Homem CC, Steinmann V, Burkard TR, Jais A, Esterbauer H, Knoblich JA. Ecdysone and mediator change energy metabolism to terminate proliferation in Drosophila neural stem cells. Cell. 2014;158(4):874-88. 41.Quadrato G, Zhang AC, Arlotta P. Stressed out? Healing Tips for Newly Reprogrammed Neurons. Cell stem cell. 2016;18(3):297-9. 42.Menon S, Shailendra S, Renda A, Longaker M, Quarto N. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Int J Mol Sci. 2016;17(1). 43.Consortium HDi. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell stem cell. 2012;11(2):264-78. 44.Byers B, Cord B, Nguyen HN, Schule B, Fenno L, Lee PC, et al. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS One. 2011;6(11):e26159. 45.Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136(5):964-77. 46.Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, Degroot S, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126(3):385-99. 47.Almeida S, Zhang Z, Coppola G, Mao W, Futai K, Karydas A, et al. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep. 2012;2(4):789-98. 48.Li Y, Balasubramanian U, Cohen D, Zhang PW, Mosmiller E, Sattler R, et al. A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells. PLoS One. 2015;10(3):e0118266. 49.Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature. 2012;482(7384):216-20. 50.Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell stem cell. 2014;14(6):796-809. 51.Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012;4(145):145ra04. 52.Xia G, Santostefano K, Hamazaki T, Liu J, Subramony SH, Terada N, et al. Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci. 2013;51(2):237-48. 53.Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476(7359):228-31. 54.Pfisterer U, Wood J, Nihlberg K, Hallgren O, Bjermer L, Westergren-Thorsson G, et al. Efficient induction of functional neurons from adult human fibroblasts. Cell Cycle. 2011;10(19):3311-6. 55.Sun CK, Zhou D, Zhang Z, He L, Zhang F, Wang X, et al. Senescence impairs direct conversion of human somatic cells to neurons. Nat Commun. 2014;5:4112. 56.Shi Z, Shen T, Liu Y, Huang Y, Jiao J. Retinoic acid receptor gamma (Rarg) and nuclear receptor subfamily 5, group A, member 2 (Nr5a2) promote conversion of fibroblasts to functional neurons. J Biol Chem. 2014;289(10):6415-28. 57.Wang P, Zhang HL, Li W, Sha H, Xu C, Yao L, et al. Generation of patient-specific induced neuronal cells using a direct reprogramming strategy. Stem Cells Dev. 2014;23(1):16-23. 58.Giorgetti A, Marchetto MC, Li M, Yu D, Fazzina R, Mu Y, et al. Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(31):12556-61. 59.Zhao J, He H, Zhou K, Ren Y, Shi Z, Wu Z, et al. Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. PLoS One. 2012;7(7):e41506. 60.Adler AF, Grigsby CL, Kulangara K, Wang H, Yasuda R, Leong KW. Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol Ther Nucleic Acids. 2012;1:e32. 61.Yang Y, Jiao J, Gao R, Yao H, Sun XF, Gao S. Direct conversion of adipocyte progenitors into functional neurons. Cell Reprogram. 2013;15(6):484-9. 62.Meng F, Chen S, Miao Q, Zhou K, Lao Q, Zhang X, et al. Induction of fibroblasts to neurons through adenoviral gene delivery. Cell Res. 2012;22(2):436-40. 63.Price JD, Park KY, Chen J, Salinas RD, Cho MJ, Kriegstein AR, et al. The Ink4a/Arf locus is a barrier to direct neuronal transdifferentiation. J Neurosci. 2014;34(37):12560-7. 64.Petersen GF, Strappe PM. Generation of diverse neural cell types through direct conversion. World J Stem Cells. 2016;8(2):32-46.
|